rs775437084
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PP5_Very_Strong
The NM_004863.4(SPTLC2):c.547C>T(p.Arg183Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,868 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004863.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTLC2 | NM_004863.4 | c.547C>T | p.Arg183Trp | missense_variant | Exon 4 of 12 | ENST00000216484.7 | NP_004854.1 | |
SPTLC2 | XM_011537384.3 | c.547C>T | p.Arg183Trp | missense_variant | Exon 4 of 10 | XP_011535686.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251484Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135916
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461868Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727236
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neuropathy, hereditary sensory and autonomic, type 1C Pathogenic:2Other:1
Variant interpreted as Pathogenic and reported on 08-04-2017 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 183 of the SPTLC2 protein (p.Arg183Trp). This variant is present in population databases (rs775437084, gnomAD 0.004%). This missense change has been observed in individual(s) with autosomal dominant hereditary sensory and autonomic neuropathy type 1C (PMID: 26573920). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 487224). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SPTLC2 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects SPTLC2 function (PMID: 26573920). For these reasons, this variant has been classified as Pathogenic. -
The variant was found to segregate with the disease phenotype in several individuals from two unrelated families. Pathogenicity was confirmed by documenting elevated deoxysphingolipids in serum of affected individuals. -
not provided Pathogenic:2
SPTLC2: PP1:Strong, PM1, PS4:Moderate, PM2:Supporting, PS3:Supporting, BP4 -
The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant associates with disease in multiple families. Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 26573920) -
Inborn genetic diseases Pathogenic:1
The p.R183W variant (also known as c.547C>T), located in coding exon 4 of the SPTLC2 gene, results from a C to T substitution at nucleotide position 547. The arginine at codon 183 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration was reported to segregate with disease in two families with hereditary sensory and autonomic neuropathy 1. These individuals had mild progressive distal sensory impairment with an onset after the age of 50 years and motor impairment presenting later (Suriyanarayanan S et al. Neuromolecular Med., 2016 Mar;18:81-90). An additional patient was reported with sensory loss and neurological pain with onset at 10 years (Bacquet J et al. BMJ Open, 2018 10;8:e021632). Functional analysis demonstrated that cells transfected with the p.R183W alteration had significantly increased 1-deoxySLs formation compared to wildtype (Suriyanarayanan S et al. Neuromolecular Med., 2016 Mar;18:81-90).This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at